IMDX Insider Trading Activity and SEC Form 4 Filings
IMDX insider trading summary
Over the past 12 months, insiders at Insight Molecular Diagnostics Inc. (IMDX) reported 6 open-market purchases worth $9.0M by 3 insiders and no sales on SEC Form 4. Net insider buying was $9.0M.
Latest IMDX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 10, 2026 | Broadwood Partners, L.P. | 10% Owner | Buy | $3.0M (521,739 @ $5.75) |
| Feb 10, 2026 | Broadwood Capital Inc | 10% Owner | Buy | $3.0M (521,739 @ $5.75) |
| Feb 10, 2026 | Neal C Bradsher | 10% Owner | Buy | $3.0M (521,739 @ $5.75) |
| Feb 10, 2026 | Broadwood Partners, L.P. | 10% Owner | Buy | $0 (0 @ $0.00) |
| Feb 10, 2026 | Broadwood Capital Inc | 10% Owner | Buy | $0 (0 @ $0.00) |
| Feb 10, 2026 | Neal C Bradsher | 10% Owner | Buy | $0 (0 @ $0.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.